Manganese produce a parkinsonism-like illness characterized by movement abnormalities. This condition is not responsive to typical therapies used in the treatment of PD, suggesting an alternative pathway than the typical dopaminergic loss within the substantia nigra. Manganese may accumulate in the basal ganglia, leading to the abnormal movements. A mutation of the SLC30A10 gene, a manganese efflux transporter necessary for decreasing intracellular Mn, has been linked with the development of this Parkinsonism-like disease. The Lewy bodies typical to PD are not seen in Mn-induced parkinsonism. Animal experiments have given the opportunity to examine the consequences of manganese overexposure under controlled conditions.
Hazard symbol carry a significant health risk (biohazards), including viral samples and used hypodermic needles (see sharps waste). The biohazard symbol was developed by the Dow Chemical Company in 1966 for their containment products. According to Charles Baldwin, an environmental-health engineer who contributed to its development: "We wanted something that was memorable but meaningless, so we could educate people as to what it means." In an article in "Science" in 1967, the symbol was presented as the new standard for all biological hazards ("biohazards"). The article explained that over 40 symbols were drawn up by Dow artists, and all of the symbols